Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 57914 [2022-20528]
Download as PDF
<![CDATA[
57914
Federal Register / Vol. 87, No. 183 / Thursday, September 22, 2022 / Notices
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–20572 Filed 9–21–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the CDC/HRSA Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Secretary’s
Centers for Disease Control and
Prevention (CDC)/HRSA Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment (CHAC)
has scheduled a public meeting.
Information about CHAC and the agenda
for this meeting can be found on the
CHAC website at https://www.cdc.gov/
maso/facm/facmCHACHSPT.html and
the meeting website at https://
targethiv.org/ta-org/chac.
DATES:
• November 1, 2022, 12:30 p.m.–5:00
p.m. Eastern Time (ET);
• November 2, 2022, 12:30 p.m.–5:30
p.m. ET; and
• November 3, 2022, 12:30 p.m.–4:00
p.m. ET.
ADDRESSES: This meeting will be held
virtually. Advance registration is
required to attend. Please visit the
meeting website to register. The
registration deadline is Friday, October
28, 2022, at 12:00 p.m. ET. Prior to the
meeting, each individual registrant will
receive a registration confirmation along
with an access link to the virtual
meeting location.
• Meeting website link: https://
targethiv.org/ta-org/chac.
FOR FURTHER INFORMATION CONTACT:
Theresa Jumento, Senior Public Health
jspears on DSK121TN23PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:32 Sep 21, 2022
Jkt 256001
Advisor, HIV/AIDS Bureau, HRSA, 301–
443–5807; or CHACAdvisoryComm@
hrsa.gov.
CHAC
provides advice and recommendations
to the Secretary of HHS (Secretary) on
policy, program development, and other
matters of significance concerning the
activities under Section 222 of the
Public Health Service Act, 42 U.S.C.
217a.
The purpose of the CHAC is to advise
the Secretary of HHS, the Director of
CDC, and the HRSA Administrator
regarding objectives, strategies, policies,
and priorities for the prevention and
treatment of HIV, viral hepatitis, and
other STDs, including: surveillance,
epidemiologic, behavioral, health
services, and laboratory research,
identification of policy issues related to
professional eduction, patient
healthcare delivery, and prevention
services; Agency policies regarding
health care delivery, research and
training; strategic issues influencing the
ability of CDC and HRSA to fulfill their
missions programmatic efforts to
prevent and treat HIV, viral hepatitis,
and other STDs; and support to the CDC
and HRSA in their development of
responses to emerging health needs
related to these issues.
During the November 1–3, 2022,
meeting, CHAC will discuss issues
related to HIV and the workforce,
including non-traditional partnerships
to address people with HIV who are out
of care, AIDS Education and Training
Center program and integrating
innovative programs to address HIV
workforce challenges into the Ryan
White HIV/AIDS Program, and how to
more effectively use community health
workers and disease intervention
specialists in HIV and STD prevention,
care, and treatment, along with a federal
update on Monkeypox. Agenda items
are subject to change as priorities
dictate. Refer to the CHAC meeting
information page for any updated
information concerning the meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may also submit
written statements as further described
below. Oral comments will be honored
in the order they are requested and may
be limited as time allows. Requests to
submit a written statement or make oral
comments to CHAC should be sent via
the meeting website at https://
targethiv.org/ta-org/chac. Requests for
oral comment must be received by
October 25, 2022, at 5 p.m. ET to be
considered. Written comments may be
submitted to Theresa Jumento at the
email address and/or phone number
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
listed above prior to and up to ten
business days after the meeting. Visit
the meeting information page for
additional details: https://targethiv.org/
ta-org/chac.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Theresa Jumento at the email
address and/or phone number listed
above at least 10 business days prior to
the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–20528 Filed 9–21–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–4040–0004]
Agency Information Collection
Request. 30-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before October 24, 2022
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Sagal Musa, sagal.musa@hhs.gov or
(202) 205–2634. When submitting
comments or requesting information,
please include the document identifier
4040–0004–30D and project title for
reference.
SUMMARY:
Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
SUPPLEMENTARY INFORMATION:
E:\FR\FM\22SEN1.SGM
22SEN1
]]>Agencies
[Federal Register Volume 87, Number 183 (Thursday, September 22, 2022)]
[Notices]
[Page 57914]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20528]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Secretary's Centers for Disease Control and
Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment (CHAC) has scheduled a public meeting.
Information about CHAC and the agenda for this meeting can be found on
the CHAC website at https://www.cdc.gov/maso/facm/facmCHACHSPT.html and
the meeting website at https://targethiv.org/ta-org/chac.
DATES:
November 1, 2022, 12:30 p.m.-5:00 p.m. Eastern Time (ET);
November 2, 2022, 12:30 p.m.-5:30 p.m. ET; and
November 3, 2022, 12:30 p.m.-4:00 p.m. ET.
ADDRESSES: This meeting will be held virtually. Advance registration is
required to attend. Please visit the meeting website to register. The
registration deadline is Friday, October 28, 2022, at 12:00 p.m. ET.
Prior to the meeting, each individual registrant will receive a
registration confirmation along with an access link to the virtual
meeting location.
Meeting website link: https://targethiv.org/ta-org/chac.
FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Senior Public Health
Advisor, HIV/AIDS Bureau, HRSA, 301-443-5807; or
[email protected].
SUPPLEMENTARY INFORMATION: CHAC provides advice and recommendations to
the Secretary of HHS (Secretary) on policy, program development, and
other matters of significance concerning the activities under Section
222 of the Public Health Service Act, 42 U.S.C. 217a.
The purpose of the CHAC is to advise the Secretary of HHS, the
Director of CDC, and the HRSA Administrator regarding objectives,
strategies, policies, and priorities for the prevention and treatment
of HIV, viral hepatitis, and other STDs, including: surveillance,
epidemiologic, behavioral, health services, and laboratory research,
identification of policy issues related to professional eduction,
patient healthcare delivery, and prevention services; Agency policies
regarding health care delivery, research and training; strategic issues
influencing the ability of CDC and HRSA to fulfill their missions
programmatic efforts to prevent and treat HIV, viral hepatitis, and
other STDs; and support to the CDC and HRSA in their development of
responses to emerging health needs related to these issues.
During the November 1-3, 2022, meeting, CHAC will discuss issues
related to HIV and the workforce, including non-traditional
partnerships to address people with HIV who are out of care, AIDS
Education and Training Center program and integrating innovative
programs to address HIV workforce challenges into the Ryan White HIV/
AIDS Program, and how to more effectively use community health workers
and disease intervention specialists in HIV and STD prevention, care,
and treatment, along with a federal update on Monkeypox. Agenda items
are subject to change as priorities dictate. Refer to the CHAC meeting
information page for any updated information concerning the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may also submit written statements as
further described below. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to CHAC should be sent
via the meeting website at https://targethiv.org/ta-org/chac. Requests
for oral comment must be received by October 25, 2022, at 5 p.m. ET to
be considered. Written comments may be submitted to Theresa Jumento at
the email address and/or phone number listed above prior to and up to
ten business days after the meeting. Visit the meeting information page
for additional details: https://targethiv.org/ta-org/chac.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Theresa Jumento at the
email address and/or phone number listed above at least 10 business
days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-20528 Filed 9-21-22; 8:45 am]
BILLING CODE 4165-15-P
